AGP
Artia Global Partners Portfolio holdings
AUM
$389M
This Quarter Return
+42.93%
1 Year Return
+34.68%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$408M
AUM Growth
+$408M
(+61%)
Cap. Flow
+$82.4M
Cap. Flow
% of AUM
20.2%
Top 10 Holdings %
Top 10 Hldgs %
79.23%
Holding
52
New
23
Increased
12
Reduced
1
Closed
3
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$12.1M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$11.7M |
| 3 |
Merck
MRK
|
$6.6M |
| 4 |
Disc Medicine
IRON
|
$5.42M |
| 5 |
Viking Therapeutics
VKTX
|
$4.1M |
Top Sells
| 1 |
Novo Nordisk
NVO
|
$3.82M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$2.79M |
| 3 |
Waters Corp
WAT
|
$937K |
| 4 |
Tyra Biosciences
TYRA
|
$142K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Waters Corp
WAT
$18B
| – | – |
-2,845
| Closed | -$937K |
|
|
EFTR
52
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| – | – |
0
| – | – |
|